Exact Sciences (EXAS) Misses Q1 EPS by 12c; maintains guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Total Operating expenses: 54.23M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Financial Fact:
Total Operating expenses: 54.23M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q1 EPS of ($0.60), $0.12 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $638 million versus the consensus estimate of $627.35 million.
GUIDANCE:
Exact Sciences sees FY2024 revenue of $2.81-2.85 billion, versus the consensus of $2.833 billion.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Oceaneering (OII) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
